Angelica Fasolo Selected Research

Indicators and Reagents (Reagents)

9/2009

Translational research in phase I trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angelica Fasolo Research Topics

Disease

9	Neoplasms (Cancer) 06/2022 - 11/2008
7	Breast Neoplasms (Breast Cancer) 01/2021 - 10/2006
3	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 01/2021
2	Disease Progression 01/2022 - 01/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2012 - 03/2011
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2012 - 03/2011
1	Glioma (Gliomas) 01/2022
1	Epilepsy (Aura) 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Anaplastic Thyroid Carcinoma 10/2020
1	Cholangiocarcinoma 01/2020
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2012
1	Heart Failure 02/2009
1	Cardiotoxicity 02/2009

Drug/Important Bio-Agent (IBA)

5	Everolimus FDA Link 01/2016 - 11/2008
3	Biomarkers (Surrogate Marker)IBA 06/2022 - 09/2009
3	Trastuzumab (Herceptin)FDA Link 01/2016 - 02/2009
3	MTOR InhibitorsIBA 01/2012 - 11/2008
3	temsirolimus FDA Link 01/2012 - 11/2008
2	spartalizumabIBA 06/2022 - 10/2020
2	dabrafenibIBA 01/2022 - 01/2020
2	trametinibIBA 01/2022 - 01/2020
2	Sorafenib (BAY 43-9006)FDA Link 08/2021 - 01/2021
2	tepotinibIBA 08/2021 - 01/2021
2	ridaforolimusIBA 03/2011 - 11/2008
1	roblitinibIBA 06/2022
1	CateninsIBA 01/2021
1	TAS-119IBA 01/2021
1	NVP-BKM120IBA 01/2021
1	AlpelisibIBA 01/2021
1	Fulvestrant (Faslodex)FDA Link 01/2021
1	ribociclibIBA 01/2021
1	Aurora Kinase AIBA 01/2021
1	Monoclonal AntibodiesIBA 10/2020
1	Gemcitabine FDA Link 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Estrogen ReceptorsIBA 01/2013
1	Tamoxifen FDA LinkGeneric 01/2013
1	Letrozole (Femara)FDA LinkGeneric 01/2013
1	Estrogens (Estrogen)FDA Link 01/2013
1	Sirolimus (Rapamycin)FDA Link 03/2011
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2011
1	Indicators and Reagents (Reagents)IBA 09/2009
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2006
1	Capecitabine (Xeloda)FDA Link 10/2006
1	CarbamatesIBA 10/2006
1	Fluorouracil (Carac)FDA LinkGeneric 10/2006
1	Methotrexate (Mexate)FDA LinkGeneric 10/2006
1	ProdrugsIBA 10/2006

Therapy/Procedure

5	Therapeutics 01/2021 - 02/2009
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
1	Chemoradiotherapy 01/2022
1	Radiotherapy 01/2022